• News
  • SAN DIEGO
  • Technology

Cytori receives notice of intent to exercise Option 1 of BARDA contract

San Diego's Cytori Therapeutics (Nasdaq: CYTX) received a preliminary written notice of intent to exercise Option 1 of its contract with the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Cytori Therapeutics

Company Website

3020 Callan Road
San Diego, CA 92121

Subscribe Today!